- Award ID(s):
- 1650474
- NSF-PAR ID:
- 10091252
- Date Published:
- Journal Name:
- International Conference on Pattern Recognition (ICPR)
- Page Range / eLocation ID:
- 2301 to 2307
- Format(s):
- Medium: X
- Sponsoring Org:
- National Science Foundation
More Like this
-
Electrocardiography (ECG) is the process of recording the electrical activity of the human heart over time using electrodes that are placed over the skin. While the primary usage of electrocardiograms, the recorded signals, has been focused on the check of signs of heart-related diseases, recent studies have moved also toward their usage for human authentication. Thus, an ECG signal can be unique enough to be used independently as a biometric modality. In addition to its inherent liveness detection, it is easy to collect and can be easily captured either via sensors attached to the human body (fingertips, chest, wrist) or even passively using wireless sensors. In this paper, we propose a novel approach that exploits the spectro-temporal dynamic characteristics of the ECG signal to establish personal recognition system using both short-time Fourier transform (STFT) and generalized Morse wavelets (CWT). This process results in enriching the information extracted from the original ECG signal that is inserted in a 2D convolutional neural network (CNN) which extracts higher level and subject-specific ECG-based features for each individual. To validate our proposed CNN model, we performed nested cross-validation using eight different ECG databases. These databases are considered challenging since they include both normal and abnormal heartbeats as well as a dynamic number of subjects. Our proposed algorithms yield superior performance when compared to other state-ofart approaches discussed in the literature, i.e. the STFT-based one achieves an average identification rate, equal error rate (EER), and area under curve (AUC) of 97.86%, 0.0268, and 0.9933 respectively, whereas the CWT achieves comparable to STFT results in 97.5%, 0.0386, and 0.9882 respectively.more » « less
-
null (Ed.)Atrial Fibrillation (AF) is among one of the most common types of heart arrhythmia afflicting more than 3 million people in the U.S. alone. AF is estimated to be the cause of death of 1 in 4 individuals. Recent advancements in Artificial Intelligence (AI) algorithms have led to the capability of reliably detecting AF from ECG signals. While these algorithms can accurately detect AF with high precision, the discrete and deterministic classifications mean that these networks are likely to erroneously classify the given ECG signal. This paper proposes a variational autoencoder classifier network that provides an uncertainty estimation of the network's output in addition to reliable classification accuracy. This framework can increase physicians' trust in using AI-based AF detection algorithms by providing them with a confidence score which reflects how uncertain the algorithm is about a case and recommending them to put more attention to the cases with a lower confidence score. The uncertainty is estimated by conducting multiple passes of the input through the network to build a distribution; the mean of the standard deviations is reported as the network's uncertainty. Our proposed network obtains 97.64% accuracy in addition to reporting the uncertainty.more » « less
-
null (Ed.)Abstract Life‐threatening ventricular arrhythmias and sudden cardiac death are often preceded by cardiac alternans, a beat‐to‐beat oscillation in the T‐wave morphology or duration. However, given the spatiotemporal and structural complexity of the human heart, designing algorithms to effectively suppress alternans and prevent fatal rhythms is challenging. Recently, an antiarrhythmic constant diastolic interval pacing protocol was proposed and shown to be effective in suppressing alternans in 0‐, 1‐, and 2‐dimensional in silico studies as well as in ex vivo whole heart experiments. Herein, we provide a systematic review of the electrophysiological conditions and mechanisms that enable constant diastolic interval pacing to be an effective antiarrhythmic pacing strategy. We also demonstrate a successful translation of the constant diastolic interval pacing protocol into an ECG‐based real‐time control system capable of modulating beat‐to‐beat cardiac electrical activity and preventing alternans. Furthermore, we present evidence of the clinical utility of real‐time alternans suppression in reducing arrhythmia susceptibility in vivo. We provide a comprehensive overview of this promising pacing technique, which can potentially be translated into a clinically viable device that could radically improve the quality of life of patients experiencing abnormal cardiac rhythms.more » « less
-
Abstract Atrial fibrillation (AF) is the most common arrhythmia and is associated with inflammation. AF patients have elevated levels of inflammatory cytokines known to promote vascular leak, such as vascular endothelial growth factor A (VEGF). However, the contribution of vascular leak and consequent cardiac edema to the genesis of atrial arrhythmias remains unknown. Previous work suggests that interstitial edema in the heart can acutely promote ventricular arrhythmias by disrupting ventricular myocyte intercalated disk (ID) nanodomains rich in cardiac sodium channels (NaV1.5) and slowing cardiac conduction. Interestingly, similar disruption of ID nanodomains has been identified in atrial samples from AF patients. Therefore, we tested the hypothesis that VEGF-induced vascular leak can acutely increase atrial arrhythmia susceptibility by disrupting ID nanodomains and slowing atrial conduction. Treatment of murine hearts with VEGF (30–60 min, at clinically relevant levels) prolonged the electrocardiographic P wave and increased susceptibility to burst pacing-induced atrial arrhythmias. Optical voltage mapping revealed slower atrial conduction following VEGF treatment (10 ± 0.4 cm/s vs. 21 ± 1 cm/s at baseline,
p < 0.05). Transmission electron microscopy revealed increased intermembrane spacing at ID sites adjacent to gap junctions (GJs; 64 ± 9 nm versus 17 ± 1 nm in controls,p < 0.05), as well as sites next to mechanical junctions (MJs; 63 ± 4 nm versus 27 ± 2 nm in controls,p < 0.05) in VEGF–treated hearts relative to controls. Importantly, super-resolution microscopy and quantitative image analysis revealed reorganization of NaV1.5 away from dense clusters localized near GJs and MJs to a more diffuse distribution throughout the ID. Taken together, these data suggest that VEGF can acutely predispose otherwise normal hearts to atrial arrhythmias by dynamically disrupting NaV1.5-rich ID nanodomains and slowing atrial conduction. These data highlight inflammation-induced vascular leak as a potential factor in the development and progression of AF. -
Abstract Background Chagas disease, caused by the protozoan parasite
Trypanosoma cruzi , causes sudden death and chronic heart disease with no currently approved treatment.Objective To report epidemiologic and select cardiac characteristics associated with
T. cruzi infection in dogs presenting to a teaching hospital in Texas.Animals Three hundred seventy‐five client‐owned dogs.
Methods A retrospective search of medical records identified dogs tested for
T. cruzi antibodies or with histologicT. cruzi parasites. Data retrieved included signalment, location of residence, reported reason for testing, cardiac troponin I (cTnI) concentration, and ECG abnormalities.Results Trypanosoma cruzi ‐infected dogs (N = 63, 16.8%) were significantly younger than negative dogs (N = 312) (mean, 5.9 ± 3.8 versus 7.4 ± 4.0 years;P = .007) with no difference by sex or breed. Ninety‐one breeds were tested; the highest percent infected were non‐sporting (10/35; 29%) and toy breed (10/42; 24%) groups. The odds of infection were 13 times greater among dogs with an infected housemate or littermate (95% confidence interval [CI], 3.94‐50.45;P < .001). Infected dogs were more likely to have ventricular arrhythmias (odds ratio [OR], 2.19; 95% CI, 1.15‐4.33,P = .02), combinations of ECG abnormalities (OR, 2.91; 95% CI, 1.37‐5.99;P = .004), and cTnI >0.129 ng/mL (ADVIA; OR, 10.71; 95% CI, 1.60‐212.21;P = .035).Conclusions and Clinical Importance Dogs infected with
T. cruzi were identified in Texas in many breed groups including breeds affected by well‐described heart diseases that mimic Chagas disease suggesting a need for increased awareness, including knowledge of when to consider testing.